Showing results (1-10 of 305) with videos related to
Sort By:
Pageof 31
International Journal of Rheumatic Diseases|April 18, 2015
Biomarkers in lupus nephritisRamnath Misra, Ranjan GuptaClinical and Experimental Rheumatology|July 28, 2015
Urinary prostaglandin D synthase as biomarker in lupus nephritis: a longitudinal studyRanjan Gupta, Akhilesh Yadav, Ramnath Misra, et al.International Journal of Rheumatic Diseases|November 9, 2017
Differences between adult and pediatric onset Henoch-Schonlein purpura from North IndiaVikas Gupta, Amita Aggarwal, Ranjan Gupta, et al.International Journal of Rheumatic Diseases|January 31, 2019
Takayasu arteritis: A distinct syndrome of large vessel vasculitis: A view point by late Professor Paul BaconRamnath MisraLupus|August 19, 2020
Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow upSujata Ganguly, Sanjukta Majumder, Sandeep Kumar, et al.Rheumatology International|May 10, 2003
Methotrexate inhibits interleukin-6 production in patients with juvenile rheumatoid arthritisAmita Aggarwal, Ramnath MisraInternational Journal of Rheumatic Diseases|September 2, 2024
Update on Takayasu arteritis: Year in review 2024Prakashini Mruthyunjaya, Ramnath MisraJournal of Proteome Research|June 8, 2018
NMR-Based Serum Metabolomics Reveals Reprogramming of Lipid Dysregulation Following Cyclophosphamide-Based Induction Therapy in Lupus NephritisAnupam Guleria, Sanat Phatak, Durgesh Dubey, et al.Rheumatology International|July 18, 2002
Methotrexate twice weekly vs once weekly in rheumatoid arthritis: a pilot double-blind, controlled studySapan Pandya, Amita Aggarwal, Ramnath MisraThe Journal of the Association of Physicians of India|October 13, 2016
Ovarian Insufficiency is Major Short-term Toxicity in Systemic Lupus Erythematosus Patients Treated with CyclophosphamideGurmeet Singh, Ramnath Misra, Amita AggarwalPageof 31